Ocuphire Pharma Total Non-Operating Income/Expense 2010-2024 | IRD

Ocuphire Pharma total non-operating income/expense from 2010 to 2024. Total non-operating income/expense can be defined as the sum of all non-operating expenses for the given industry.
Ocuphire Pharma Annual Total Non-Operating Income/Expense
(Millions of US $)
2023 $1
2022 $-0
2021 $-34
2020 $-5
2019 $-2
2018 $6
2017 $-8
2016 $7
2015 $4
2014 $-5
2013 $-2
2012 $0
2011 $5
2010 $-4
2009 $4
Ocuphire Pharma Quarterly Total Non-Operating Income/Expense
(Millions of US $)
2024-06-30 $1
2024-03-31 $1
2023-12-31 $1
2023-09-30 $-1
2023-06-30 $0
2023-03-31 $0
2022-12-31 $0
2022-09-30 $0
2022-06-30 $0
2022-03-31 $-0
2021-12-31 $-0
2021-09-30 $0
2021-06-30 $0
2021-03-31 $-34
2020-12-31 $-5
2020-09-30 $1
2020-06-30 $-0
2020-03-31 $-0
2019-12-31 $-4
2019-09-30 $0
2019-06-30 $1
2019-03-31 $2
2018-12-31 $2
2018-09-30 $-1
2018-06-30 $1
2018-03-31 $4
2017-12-31 $1
2017-09-30 $3
2017-06-30 $5
2017-03-31 $-18
2016-12-31 $3
2016-09-30 $1
2016-06-30 $2
2016-03-31 $1
2015-12-31 $2
2015-09-30 $1
2015-06-30 $2
2015-03-31 $0
2014-12-31 $2
2014-09-30 $1
2014-06-30 $4
2014-03-31 $-12
2013-12-31 $-0
2013-09-30 $-0
2013-06-30 $-1
2013-03-31 $0
2012-12-31 $1
2012-09-30 $-1
2012-06-30 $1
2012-03-31 $-0
2011-12-31 $3
2011-09-30 $2
2011-06-30 $1
2011-03-31 $-1
2010-12-31 $1
2010-09-30 $3
2010-06-30 $-0
2010-03-31 $-6
2009-12-31 $4
2009-09-30 $0
2009-06-30 $0
2009-03-31 $0
Sector Industry Market Cap Revenue
$0.000B $0.000B
Ocuphire Pharma Inc. is a clinical-stage ophthalmic biopharmaceutical company. It is focused on developing and commercializing therapies for the treatment of several eye disorders. The company's product pipeline includes Nyxol Eye Drops(R) and APX3330. Ocuphire Pharma Inc., formerly known as Rexahn Pharmaceuticals Inc., is based in FARMINGTON HILLS, Mich.
Stock Name Country Market Cap PE Ratio
Fanhua (AIFU) China $0.086B 2.07
Top KingWin (WAI) China $0.008B 0.00
S&W Seed (SANW) United States $0.006B 0.00
Invo BioScience (NAYA) United States $0.004B 0.00